Literature DB >> 11857393

Familial and second esophageal cancers: a nation-wide epidemiologic study from Sweden.

Kari Hemminki1, Yongwen Jiang.   

Abstract

A few case-control studies have been published on familial risks in esophageal cancer. Reliable data on familial risks are needed for prevention and clinical decisions. We used the nation-wide Swedish Family-Cancer Database on 10.1 million individuals and close to 6000 esophageal cancers to calculate standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) for esophageal cancer in 0-66-year-old offspring by cancers in family members. Additionally, SIRs for second esophageal cancers were analyzed. The SIR for esophageal cancer was 3.91 (95% CI 1.55-7.35) when a parent presented with esophageal cancer and 4.91 (95% CI 1.77-9.62) when a parent presented with squamous cell carcinoma. The sibling risk for esophageal cancer was increased but was based on 1 pair only. The population-attributable proportion of familial esophageal cancer was 0.70%. Risks for second esophageal cancers were increased after upper aerodigestive tract, esophageal, stomach, larynx, and lung cancers. The data on second cancers suggest that environmental factors are important for esophageal cancer and probably contribute to the familial clustering. However, the high familial risk of 3.91 is unlikely without the involvement of heritable factors. The population-attributable proportion of familial esophageal cancer is small. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11857393     DOI: 10.1002/ijc.10172

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

Review 1.  Multidisciplinary approach for patients with esophageal cancer.

Authors:  Victoria M Villaflor; Marco E Allaix; Bruce Minsky; Fernando A Herbella; Marco G Patti
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

Review 2.  Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans.

Authors:  K Hemminki; C Eng
Journal:  J Med Genet       Date:  2004-11       Impact factor: 6.318

3.  Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden.

Authors:  K Hemminki; X Li
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

4.  Familial risk of urological cancers: data for clinical counseling.

Authors:  Kari Hemminki; Xinjun Li; Kamila Czene
Journal:  World J Urol       Date:  2003-11-13       Impact factor: 4.226

5.  Determination of Effective Factors on Survival of GI Cancers: Results of Five Years Follow up in Iranian Population.

Authors:  Ali Zargar; Arash Miroliaee; Somayeh Ahmadi Gooraji; Aliakbar Hajaghamohammadi
Journal:  Glob J Health Sci       Date:  2015-11-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.